Nutrition and lifestyle support Food choices, movement, sleep, stress management, and other daily habits frequently play an important role
What the Research Found The research, published in the Annals of Internal Medicine , examined whether people with type 2 diabetes taking GLP-1 receptor agonists such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) face a higher risk of ischaemic optic neuropathy
Semaglutide studies showed up to 40% of total weight lost came from lean mass in some participants
It is available either as a 10 mcg twice daily subcutaneous injection or as a 2 mg once weekly preparation
Eddie Hughes, FNP-BC Eddie is a board-certified Family Nurse Practitioner with 15+ years of clinical experience spanning emergency medicine, neurosurgery, hospital medicine, and regenerative medicine
The GLP-1 Support Menu comprises five smoothies developed in partnership with Molly Kimball, a registered dietitian at Ochsner Health who leads a programme highlighting nutritious meal options at popular restaurants